Zevra Therapeutics, Inc. (ZVRA)

8.93 -0.09 (-1.00%) USD  |  NASDAQ  |  Jan 16, 16:00
9.10 +0.17 (+1.90%) After-Hours: 20:00
More

Zevra Therapeutics Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Verastem, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade